+关注
Jamz_stocks
暂无个人介绍
IP属地:未知
5
关注
2
粉丝
0
主题
0
勋章
主贴
热门
Jamz_stocks
2021-12-04
3rd time in a row.. he sells whenever i buy
抱歉,原内容已删除
Jamz_stocks
2021-12-19
Fly
Novavax, Vir among healthcare gainers, Pfizer posts best rally in a decade<blockquote>Novavax、Vir跻身医疗保健股涨幅之列,辉瑞(Pfizer)创下十年来最佳涨幅</blockquote>
Jamz_stocks
2021-12-03
Knew it
Elon Musk continued to sell his Tesla stocks.<blockquote>Elon Musk继续抛售特斯拉股票。</blockquote>
Jamz_stocks
2021-12-14
looks like he's the one buying the dip
Tesla dipped nearly 2% in premarket trading as Musk sold another 934,091 shares on Monday<blockquote>特斯拉在盘前交易中下跌近2%,马斯克周一又出售了934,091股</blockquote>
Jamz_stocks
2021-12-10
What the heck is exercising options
抱歉,原内容已删除
Jamz_stocks
2021-11-24
It will go bacn up
抱歉,原内容已删除
Jamz_stocks
2021-12-14
Wow
抱歉,原内容已删除
Jamz_stocks
2021-12-12
Bold of you to assume I’ve 100000
抱歉,原内容已删除
Jamz_stocks
2021-12-01
Up up and up
GlobalFoundries forecasts upbeat sales on booming chip demand<blockquote>GlobalFoundries预测芯片需求蓬勃发展将带来乐观销售</blockquote>
去老虎APP查看更多动态
{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"4095298251443200","uuid":"4095298251443200","gmtCreate":1634129367878,"gmtModify":1634607025863,"name":"Jamz_stocks","pinyin":"jamzstocksjamzstocks","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/07784544f98dce3e8324f1d04931e866","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":2,"headSize":5,"tweetSize":9,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖(非转发)","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"228c86a078844d74991fff2b7ab2428d-2","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资总监虎","description":"证券账户累计交易金额达到30万美元","bigImgUrl":"https://static.tigerbbs.com/9d20b23f1b6335407f882bc5c2ad12c0","smallImgUrl":"https://static.tigerbbs.com/ada3b4533518ace8404a3f6dd192bd29","grayImgUrl":"https://static.tigerbbs.com/177f283ba21d1c077054dac07f88f3bd","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"80.16%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.02.26","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"35ec162348d5460f88c959321e554969-3","templateUuid":"35ec162348d5460f88c959321e554969","name":"传说交易员","description":"证券或期货账户累计交易次数达到300次","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.05.10","exceedPercentage":"93.81%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":11,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":699708064,"gmtCreate":1639886513443,"gmtModify":1639886513544,"author":{"id":"4095298251443200","authorId":"4095298251443200","name":"Jamz_stocks","avatar":"https://static.tigerbbs.com/07784544f98dce3e8324f1d04931e866","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4095298251443200","idStr":"4095298251443200"},"themes":[],"htmlText":"Fly","listText":"Fly","text":"Fly","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/699708064","repostId":"1122414343","repostType":4,"repost":{"id":"1122414343","kind":"news","pubTimestamp":1639884070,"share":"https://www.laohu8.com/m/news/1122414343?lang=zh_CN&edition=full","pubTime":"2021-12-19 11:21","market":"us","language":"en","title":"Novavax, Vir among healthcare gainers, Pfizer posts best rally in a decade<blockquote>Novavax、Vir跻身医疗保健股涨幅之列,辉瑞(Pfizer)创下十年来最佳涨幅</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1122414343","media":"Seeking Alpha","summary":"The healthcare stocks in the S&P 500 outperformed all other sectors in the broader index with a ~2.5","content":"<p>The healthcare stocks in the S&P 500 outperformed all other sectors in the broader index with a ~2.5% gain thanks mainly to M&A prospects. <a href=\"https://laohu8.com/S/HCSG\">Healthcare</a> technology, along with names battling the resurgence of COVID-19, led the gainers while the overall index fell ~1.9%.</p><p><blockquote>标普500的医疗保健股表现优于大盘指数中的所有其他板块,涨幅约为2.5%,主要得益于并购前景。<a href=\"https://laohu8.com/S/HCSG\">医疗保健</a>科技股以及与COVID-19死灰复燃作斗争的股票领涨,而整体指数下跌约1.9%。</blockquote></p><p> Among stocks with more than $2B market capitalization and 100K average daily volume over the past week, <a href=\"https://laohu8.com/S/ARNA\">Arena Pharmaceuticals </a> dominated with a ~83.8% rise after <a href=\"https://laohu8.com/S/PFE\">Pfizer </a> agreed to acquire it in a ~$6.7B deal with 100% premium for the biotech. <a href=\"https://laohu8.com/S/CERN\">Cerner </a> also joined the M&A-driven rally to gain ~20.7% over the week amid reports of a potential ~$30B bid from <a href=\"https://laohu8.com/S/ORCL\">Oracle </a> for the electronic-medical-records company.</p><p><blockquote>在过去一周市值超过20亿美元、日均成交量超过10万的股票中,<a href=\"https://laohu8.com/S/ARNA\">Arena制药公司</a>之后上涨约83.8%<a href=\"https://laohu8.com/S/PFE\">辉瑞</a>同意以约6.7 B美元的价格收购该生物技术公司,溢价100%。<a href=\"https://laohu8.com/S/CERN\">塞尔纳</a>也加入了并购推动的涨势,本周上涨约20.7%,有报道称来自<a href=\"https://laohu8.com/S/ORCL\">神谕</a>电子病历公司。</blockquote></p><p> Vaccine developer, <a href=\"https://laohu8.com/S/NVAX\">Novavax </a> jumped ~30.5% as investors welcomed the WHO clearance for the company’s COVID-19 shot. Further gains for the Maryland-based biotech are likely when an expert panel of the European regulators is set to review the marketing authorization for the vaccine next week.</p><p><blockquote>疫苗开发商、<a href=\"https://laohu8.com/S/NVAX\">Novavax</a>由于投资者欢迎世界卫生组织批准该公司的COVID-19疫苗,股价上涨约30.5%。当欧洲监管机构的专家小组将于下周审查该疫苗的营销授权时,这家总部位于马里兰州的生物技术公司可能会进一步受益。</blockquote></p><p> <a href=\"https://laohu8.com/S/BHVN\">Biohaven Pharmaceutical </a> posted a ~25.2% weekly rise after the company announced the approval for NURTEC ODT (rimegepant) in Israel, making it the first regulatory win for the migraine drug outside the U.S. Meanwhile, Vir Biotechnology (NASDAQ:VIR) surged ~23.7% to stand among best gainers for the second week this month. More data emerged this week confirming the Omicron-neutralizing effect of the company’s COVID-19 therapy developed in partnership with GlaxoSmithKline (NYSE:GSK). Rounding out the top five gainers, <a href=\"https://laohu8.com/S/ROIV\">Roivant Sciences </a> added ~22.6%.</p><p><blockquote><a href=\"https://laohu8.com/S/BHVN\">Biohaven制药</a>在该公司宣布NURTEC ODT(rimegepant)在以色列获得批准后,该公司每周上涨约25.2%,使其成为该偏头痛药物在美国以外的首个监管胜利。与此同时,Vir Biotechnology(纳斯达克股票代码:VIR)飙升约23.7%,成为本月第二周涨幅最大的股票之一。本周出现的更多数据证实了该公司与葛兰素史克(纽约证券交易所股票代码:GSK)合作开发的COVID-19疗法具有奥密克戎中和作用。跻身涨幅前五名的还有,<a href=\"https://laohu8.com/S/ROIV\">Roivant科学</a>增加了约22.6%。</blockquote></p><p> Notable gainer: <a href=\"https://laohu8.com/S/PFE\">Pfizer</a> (PFE) made headlines throughout the week, raising its sales guidance for the COVID-19 vaccine once again as the rapidly spreading Omicron variant highlighted the need for booster shots. Despite an abrupt end to its six-day rally on Friday, the <a href=\"https://laohu8.com/S/NWY\">New York</a>-based pharma giant with a ~12.7% rise recorded its best weekly gain since March 2009.</p><p><blockquote>值得注意的赢家:<a href=\"https://laohu8.com/S/PFE\">辉瑞</a>(PFE)本周成为头条新闻,再次提高了COVID-19疫苗的销售指引,因为迅速传播的奥密克戎变种凸显了加强注射的必要性。尽管周五突然结束了连续六天的涨势,<a href=\"https://laohu8.com/S/NWY\">纽约</a>总部位于美国的制药巨头股价上涨约12.7%,创下2009年3月以来的最佳单周涨幅。</blockquote></p><p> Among worst performers of the week, two newly IPO’ed biotechs, Instil Bio (NASDAQ:TIL) and Exscientia (NASDAQ:EXAI), stood out, falling 19.3% and ~13.5%, respectively, despite their favorable ratings on Wall Street. Meanwhile, GoodRx Holdings (NASDAQ:GDRX), an operator of a price comparison platform for prescription medicine slumped ~15.6%.</p><p><blockquote>在本周表现最差的公司中,两家新IPO的生物技术公司Instil Bio(纳斯达克股票代码:TIL)和Exscientia(纳斯达克股票代码:EXAI)脱颖而出,尽管它们在华尔街获得了良好的评级,但分别下跌了19.3%和约13.5%。与此同时,处方药比价平台运营商GoodRx Holdings(纳斯达克股票代码:GDRX)股价下跌约15.6%。</blockquote></p><p> Last week’s best performer, <a href=\"https://laohu8.com/S/BHG\">Bright Health Group</a>, crashed ~13.1%, hurt by the sole Sell rating issued by <a href=\"https://laohu8.com/S/GS\">Goldman Sachs</a> even as the investment bank kicked off its coverage on managed care with largely positive views.</p><p><blockquote>上周表现最好的,<a href=\"https://laohu8.com/S/BHG\">光明健康集团</a>,暴跌约13.1%,受到唯一卖出评级的伤害<a href=\"https://laohu8.com/S/GS\">高盛</a>尽管这家投资银行以基本积极的观点开始了对管理式医疗的报道。</blockquote></p><p> Allogene Therapeutics (NASDAQ:ALLO) dropped ~12.3% after the company’s ASH presentations on Phase 1 data for experimental allogeneic <a href=\"https://laohu8.com/S/00699\">CAR</a> T therapies failed to excite investors, including Cathie Wood’s Ark Investment Management, which sold ~1.6M shares of the biotech several days later.</p><p><blockquote>Allogene Therapeutics(纳斯达克股票代码:ALLO)在ASH介绍实验性同种异体药物1期数据后股价下跌约12.3%<a href=\"https://laohu8.com/S/00699\">车</a>T疗法未能让投资者兴奋,其中包括Cathie Wood的Ark Investment Management,该公司几天后出售了约160万股该生物技术公司的股票。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Novavax, Vir among healthcare gainers, Pfizer posts best rally in a decade<blockquote>Novavax、Vir跻身医疗保健股涨幅之列,辉瑞(Pfizer)创下十年来最佳涨幅</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovavax, Vir among healthcare gainers, Pfizer posts best rally in a decade<blockquote>Novavax、Vir跻身医疗保健股涨幅之列,辉瑞(Pfizer)创下十年来最佳涨幅</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Seeking Alpha</strong><span class=\"h-time small\">2021-12-19 11:21</span>\n</p>\n</h4>\n</header>\n<article>\n<p>The healthcare stocks in the S&P 500 outperformed all other sectors in the broader index with a ~2.5% gain thanks mainly to M&A prospects. <a href=\"https://laohu8.com/S/HCSG\">Healthcare</a> technology, along with names battling the resurgence of COVID-19, led the gainers while the overall index fell ~1.9%.</p><p><blockquote>标普500的医疗保健股表现优于大盘指数中的所有其他板块,涨幅约为2.5%,主要得益于并购前景。<a href=\"https://laohu8.com/S/HCSG\">医疗保健</a>科技股以及与COVID-19死灰复燃作斗争的股票领涨,而整体指数下跌约1.9%。</blockquote></p><p> Among stocks with more than $2B market capitalization and 100K average daily volume over the past week, <a href=\"https://laohu8.com/S/ARNA\">Arena Pharmaceuticals </a> dominated with a ~83.8% rise after <a href=\"https://laohu8.com/S/PFE\">Pfizer </a> agreed to acquire it in a ~$6.7B deal with 100% premium for the biotech. <a href=\"https://laohu8.com/S/CERN\">Cerner </a> also joined the M&A-driven rally to gain ~20.7% over the week amid reports of a potential ~$30B bid from <a href=\"https://laohu8.com/S/ORCL\">Oracle </a> for the electronic-medical-records company.</p><p><blockquote>在过去一周市值超过20亿美元、日均成交量超过10万的股票中,<a href=\"https://laohu8.com/S/ARNA\">Arena制药公司</a>之后上涨约83.8%<a href=\"https://laohu8.com/S/PFE\">辉瑞</a>同意以约6.7 B美元的价格收购该生物技术公司,溢价100%。<a href=\"https://laohu8.com/S/CERN\">塞尔纳</a>也加入了并购推动的涨势,本周上涨约20.7%,有报道称来自<a href=\"https://laohu8.com/S/ORCL\">神谕</a>电子病历公司。</blockquote></p><p> Vaccine developer, <a href=\"https://laohu8.com/S/NVAX\">Novavax </a> jumped ~30.5% as investors welcomed the WHO clearance for the company’s COVID-19 shot. Further gains for the Maryland-based biotech are likely when an expert panel of the European regulators is set to review the marketing authorization for the vaccine next week.</p><p><blockquote>疫苗开发商、<a href=\"https://laohu8.com/S/NVAX\">Novavax</a>由于投资者欢迎世界卫生组织批准该公司的COVID-19疫苗,股价上涨约30.5%。当欧洲监管机构的专家小组将于下周审查该疫苗的营销授权时,这家总部位于马里兰州的生物技术公司可能会进一步受益。</blockquote></p><p> <a href=\"https://laohu8.com/S/BHVN\">Biohaven Pharmaceutical </a> posted a ~25.2% weekly rise after the company announced the approval for NURTEC ODT (rimegepant) in Israel, making it the first regulatory win for the migraine drug outside the U.S. Meanwhile, Vir Biotechnology (NASDAQ:VIR) surged ~23.7% to stand among best gainers for the second week this month. More data emerged this week confirming the Omicron-neutralizing effect of the company’s COVID-19 therapy developed in partnership with GlaxoSmithKline (NYSE:GSK). Rounding out the top five gainers, <a href=\"https://laohu8.com/S/ROIV\">Roivant Sciences </a> added ~22.6%.</p><p><blockquote><a href=\"https://laohu8.com/S/BHVN\">Biohaven制药</a>在该公司宣布NURTEC ODT(rimegepant)在以色列获得批准后,该公司每周上涨约25.2%,使其成为该偏头痛药物在美国以外的首个监管胜利。与此同时,Vir Biotechnology(纳斯达克股票代码:VIR)飙升约23.7%,成为本月第二周涨幅最大的股票之一。本周出现的更多数据证实了该公司与葛兰素史克(纽约证券交易所股票代码:GSK)合作开发的COVID-19疗法具有奥密克戎中和作用。跻身涨幅前五名的还有,<a href=\"https://laohu8.com/S/ROIV\">Roivant科学</a>增加了约22.6%。</blockquote></p><p> Notable gainer: <a href=\"https://laohu8.com/S/PFE\">Pfizer</a> (PFE) made headlines throughout the week, raising its sales guidance for the COVID-19 vaccine once again as the rapidly spreading Omicron variant highlighted the need for booster shots. Despite an abrupt end to its six-day rally on Friday, the <a href=\"https://laohu8.com/S/NWY\">New York</a>-based pharma giant with a ~12.7% rise recorded its best weekly gain since March 2009.</p><p><blockquote>值得注意的赢家:<a href=\"https://laohu8.com/S/PFE\">辉瑞</a>(PFE)本周成为头条新闻,再次提高了COVID-19疫苗的销售指引,因为迅速传播的奥密克戎变种凸显了加强注射的必要性。尽管周五突然结束了连续六天的涨势,<a href=\"https://laohu8.com/S/NWY\">纽约</a>总部位于美国的制药巨头股价上涨约12.7%,创下2009年3月以来的最佳单周涨幅。</blockquote></p><p> Among worst performers of the week, two newly IPO’ed biotechs, Instil Bio (NASDAQ:TIL) and Exscientia (NASDAQ:EXAI), stood out, falling 19.3% and ~13.5%, respectively, despite their favorable ratings on Wall Street. Meanwhile, GoodRx Holdings (NASDAQ:GDRX), an operator of a price comparison platform for prescription medicine slumped ~15.6%.</p><p><blockquote>在本周表现最差的公司中,两家新IPO的生物技术公司Instil Bio(纳斯达克股票代码:TIL)和Exscientia(纳斯达克股票代码:EXAI)脱颖而出,尽管它们在华尔街获得了良好的评级,但分别下跌了19.3%和约13.5%。与此同时,处方药比价平台运营商GoodRx Holdings(纳斯达克股票代码:GDRX)股价下跌约15.6%。</blockquote></p><p> Last week’s best performer, <a href=\"https://laohu8.com/S/BHG\">Bright Health Group</a>, crashed ~13.1%, hurt by the sole Sell rating issued by <a href=\"https://laohu8.com/S/GS\">Goldman Sachs</a> even as the investment bank kicked off its coverage on managed care with largely positive views.</p><p><blockquote>上周表现最好的,<a href=\"https://laohu8.com/S/BHG\">光明健康集团</a>,暴跌约13.1%,受到唯一卖出评级的伤害<a href=\"https://laohu8.com/S/GS\">高盛</a>尽管这家投资银行以基本积极的观点开始了对管理式医疗的报道。</blockquote></p><p> Allogene Therapeutics (NASDAQ:ALLO) dropped ~12.3% after the company’s ASH presentations on Phase 1 data for experimental allogeneic <a href=\"https://laohu8.com/S/00699\">CAR</a> T therapies failed to excite investors, including Cathie Wood’s Ark Investment Management, which sold ~1.6M shares of the biotech several days later.</p><p><blockquote>Allogene Therapeutics(纳斯达克股票代码:ALLO)在ASH介绍实验性同种异体药物1期数据后股价下跌约12.3%<a href=\"https://laohu8.com/S/00699\">车</a>T疗法未能让投资者兴奋,其中包括Cathie Wood的Ark Investment Management,该公司几天后出售了约160万股该生物技术公司的股票。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源:<a href=\"https://seekingalpha.com/news/3781487-novavax-vir-among-healthcare-gainers-pfizer-posts-best-rally-in-a-decade\">Seeking Alpha</a></p>\n<p>为提升您的阅读体验,我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4533":"AQR资本管理(全球第二大对冲基金)","BK4007":"制药","BK4568":"美国抗疫概念","PFE":"辉瑞","CERN":"美国塞纳","BK4550":"红杉资本持仓","BK4534":"瑞士信贷持仓","ORCL":"甲骨文","ARNA":"阿里那"},"source_url":"https://seekingalpha.com/news/3781487-novavax-vir-among-healthcare-gainers-pfizer-posts-best-rally-in-a-decade","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1122414343","content_text":"The healthcare stocks in the S&P 500 outperformed all other sectors in the broader index with a ~2.5% gain thanks mainly to M&A prospects. Healthcare technology, along with names battling the resurgence of COVID-19, led the gainers while the overall index fell ~1.9%.\nAmong stocks with more than $2B market capitalization and 100K average daily volume over the past week, Arena Pharmaceuticals dominated with a ~83.8% rise after Pfizer agreed to acquire it in a ~$6.7B deal with 100% premium for the biotech. Cerner also joined the M&A-driven rally to gain ~20.7% over the week amid reports of a potential ~$30B bid from Oracle for the electronic-medical-records company.\nVaccine developer, Novavax jumped ~30.5% as investors welcomed the WHO clearance for the company’s COVID-19 shot. Further gains for the Maryland-based biotech are likely when an expert panel of the European regulators is set to review the marketing authorization for the vaccine next week.\nBiohaven Pharmaceutical posted a ~25.2% weekly rise after the company announced the approval for NURTEC ODT (rimegepant) in Israel, making it the first regulatory win for the migraine drug outside the U.S. Meanwhile, Vir Biotechnology (NASDAQ:VIR) surged ~23.7% to stand among best gainers for the second week this month. More data emerged this week confirming the Omicron-neutralizing effect of the company’s COVID-19 therapy developed in partnership with GlaxoSmithKline (NYSE:GSK). Rounding out the top five gainers, Roivant Sciences added ~22.6%.\nNotable gainer: Pfizer (PFE) made headlines throughout the week, raising its sales guidance for the COVID-19 vaccine once again as the rapidly spreading Omicron variant highlighted the need for booster shots. Despite an abrupt end to its six-day rally on Friday, the New York-based pharma giant with a ~12.7% rise recorded its best weekly gain since March 2009.\nAmong worst performers of the week, two newly IPO’ed biotechs, Instil Bio (NASDAQ:TIL) and Exscientia (NASDAQ:EXAI), stood out, falling 19.3% and ~13.5%, respectively, despite their favorable ratings on Wall Street. Meanwhile, GoodRx Holdings (NASDAQ:GDRX), an operator of a price comparison platform for prescription medicine slumped ~15.6%.\nLast week’s best performer, Bright Health Group, crashed ~13.1%, hurt by the sole Sell rating issued by Goldman Sachs even as the investment bank kicked off its coverage on managed care with largely positive views.\nAllogene Therapeutics (NASDAQ:ALLO) dropped ~12.3% after the company’s ASH presentations on Phase 1 data for experimental allogeneic CAR T therapies failed to excite investors, including Cathie Wood’s Ark Investment Management, which sold ~1.6M shares of the biotech several days later.","news_type":1,"symbols_score_info":{"ARNA":0.9,"ORCL":0.9,"CERN":0.9,"PFE":0.9}},"isVote":1,"tweetType":1,"viewCount":4137,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":607394909,"gmtCreate":1639486137299,"gmtModify":1639486137364,"author":{"id":"4095298251443200","authorId":"4095298251443200","name":"Jamz_stocks","avatar":"https://static.tigerbbs.com/07784544f98dce3e8324f1d04931e866","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4095298251443200","idStr":"4095298251443200"},"themes":[],"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/607394909","repostId":"1174676939","repostType":4,"isVote":1,"tweetType":1,"viewCount":2172,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":607395041,"gmtCreate":1639486073837,"gmtModify":1639486073932,"author":{"id":"4095298251443200","authorId":"4095298251443200","name":"Jamz_stocks","avatar":"https://static.tigerbbs.com/07784544f98dce3e8324f1d04931e866","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4095298251443200","idStr":"4095298251443200"},"themes":[],"htmlText":"looks like he's the one buying the dip","listText":"looks like he's the one buying the dip","text":"looks like he's the one buying the dip","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/607395041","repostId":"1166550850","repostType":4,"repost":{"id":"1166550850","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1639473176,"share":"https://www.laohu8.com/m/news/1166550850?lang=zh_CN&edition=full","pubTime":"2021-12-14 17:12","market":"us","language":"en","title":"Tesla dipped nearly 2% in premarket trading as Musk sold another 934,091 shares on Monday<blockquote>特斯拉在盘前交易中下跌近2%,马斯克周一又出售了934,091股</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1166550850","media":"Tiger Newspress","summary":"Tesla dipped nearly 2% in premarket trading as Musk sold another 934,091 shares on Monday.Tesla CEO Elon Musk sold another 934,091 shares in the automaker, worth nearly $906.5 million, on Monday, as per filings made with the U.S. Securities and Exchange Commission.Musk conducted the sale of shares to satisfy tax withholding obligations on the exercise of stock options to purchase 2.13 million shares of Tesla, as per the filings.Musk has sold 12 million shares since he tweeted on November 6 that ","content":"<p>Tesla dipped nearly 2% in premarket trading as Musk sold another 934,091 shares on Monday.<img src=\"https://static.tigerbbs.com/19cc3dded28a854d32d0ca0677db7efc\" tg-width=\"773\" tg-height=\"567\" width=\"100%\" height=\"auto\">Tesla CEO Elon Musk sold another 934,091 shares in the automaker, worth nearly $906.5 million, on Monday, as per filings made with the U.S. Securities and Exchange Commission.</p><p><blockquote>由于马斯克周一又出售了934,091股,特斯拉在盘前交易中下跌近2%。根据向美国证券交易委员会提交的文件,特斯拉首席执行官Elon Musk周一又出售了934,091股该汽车制造商的股票,价值近9.065亿美元。</blockquote></p><p> Musk conducted the sale of shares to satisfy tax withholding obligations on the exercise of stock options to purchase 2.13 million shares of Tesla, as per the filings.</p><p><blockquote>文件显示,马斯克出售股票是为了履行行使股票期权购买213万股特斯拉股票时的预扣税义务。</blockquote></p><p> Musk has sold 12 million shares since he tweeted on November 6 that he would reduce his stake in Tesla Motors by 10%.</p><p><blockquote>自11月6日马斯克发推表示将减持10%的特斯拉股份以来,马斯克已经卖出了1200万股。</blockquote></p><p> If you don't count the stocks he bought, the number of shares reduced has actually reached the goal that10% of the shares sold is equivalent to about 17 million shares.</p><p><blockquote>如果不算他买入的股票,减持的股票数量实际上已经达到了卖出股票的10%相当于1700万股左右的目标。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tesla dipped nearly 2% in premarket trading as Musk sold another 934,091 shares on Monday<blockquote>特斯拉在盘前交易中下跌近2%,马斯克周一又出售了934,091股</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTesla dipped nearly 2% in premarket trading as Musk sold another 934,091 shares on Monday<blockquote>特斯拉在盘前交易中下跌近2%,马斯克周一又出售了934,091股</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-12-14 17:12</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Tesla dipped nearly 2% in premarket trading as Musk sold another 934,091 shares on Monday.<img src=\"https://static.tigerbbs.com/19cc3dded28a854d32d0ca0677db7efc\" tg-width=\"773\" tg-height=\"567\" width=\"100%\" height=\"auto\">Tesla CEO Elon Musk sold another 934,091 shares in the automaker, worth nearly $906.5 million, on Monday, as per filings made with the U.S. Securities and Exchange Commission.</p><p><blockquote>由于马斯克周一又出售了934,091股,特斯拉在盘前交易中下跌近2%。根据向美国证券交易委员会提交的文件,特斯拉首席执行官Elon Musk周一又出售了934,091股该汽车制造商的股票,价值近9.065亿美元。</blockquote></p><p> Musk conducted the sale of shares to satisfy tax withholding obligations on the exercise of stock options to purchase 2.13 million shares of Tesla, as per the filings.</p><p><blockquote>文件显示,马斯克出售股票是为了履行行使股票期权购买213万股特斯拉股票时的预扣税义务。</blockquote></p><p> Musk has sold 12 million shares since he tweeted on November 6 that he would reduce his stake in Tesla Motors by 10%.</p><p><blockquote>自11月6日马斯克发推表示将减持10%的特斯拉股份以来,马斯克已经卖出了1200万股。</blockquote></p><p> If you don't count the stocks he bought, the number of shares reduced has actually reached the goal that10% of the shares sold is equivalent to about 17 million shares.</p><p><blockquote>如果不算他买入的股票,减持的股票数量实际上已经达到了卖出股票的10%相当于1700万股左右的目标。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1166550850","content_text":"Tesla dipped nearly 2% in premarket trading as Musk sold another 934,091 shares on Monday.Tesla CEO Elon Musk sold another 934,091 shares in the automaker, worth nearly $906.5 million, on Monday, as per filings made with the U.S. Securities and Exchange Commission.\nMusk conducted the sale of shares to satisfy tax withholding obligations on the exercise of stock options to purchase 2.13 million shares of Tesla, as per the filings.\nMusk has sold 12 million shares since he tweeted on November 6 that he would reduce his stake in Tesla Motors by 10%.\nIf you don't count the stocks he bought, the number of shares reduced has actually reached the goal that10% of the shares sold is equivalent to about 17 million shares.","news_type":1,"symbols_score_info":{"TSLA":0.9}},"isVote":1,"tweetType":1,"viewCount":1854,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":604023518,"gmtCreate":1639284670054,"gmtModify":1639298218902,"author":{"id":"4095298251443200","authorId":"4095298251443200","name":"Jamz_stocks","avatar":"https://static.tigerbbs.com/07784544f98dce3e8324f1d04931e866","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4095298251443200","idStr":"4095298251443200"},"themes":[],"htmlText":"Bold of you to assume I’ve 100000","listText":"Bold of you to assume I’ve 100000","text":"Bold of you to assume I’ve 100000","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/604023518","repostId":"2190679207","repostType":4,"isVote":1,"tweetType":1,"viewCount":1877,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":605306055,"gmtCreate":1639107989573,"gmtModify":1639108507664,"author":{"id":"4095298251443200","authorId":"4095298251443200","name":"Jamz_stocks","avatar":"https://static.tigerbbs.com/07784544f98dce3e8324f1d04931e866","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4095298251443200","idStr":"4095298251443200"},"themes":[],"htmlText":"What the heck is exercising options","listText":"What the heck is exercising options","text":"What the heck is exercising options","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/605306055","repostId":"2190641206","repostType":4,"isVote":1,"tweetType":1,"viewCount":2032,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":601757024,"gmtCreate":1638575271804,"gmtModify":1638575271804,"author":{"id":"4095298251443200","authorId":"4095298251443200","name":"Jamz_stocks","avatar":"https://static.tigerbbs.com/07784544f98dce3e8324f1d04931e866","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4095298251443200","idStr":"4095298251443200"},"themes":[],"htmlText":"3rd time in a row.. he sells whenever i buy","listText":"3rd time in a row.. he sells whenever i buy","text":"3rd time in a row.. he sells whenever i buy","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/601757024","repostId":"1158981658","repostType":4,"isVote":1,"tweetType":1,"viewCount":2266,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":601141126,"gmtCreate":1638501348367,"gmtModify":1638501348367,"author":{"id":"4095298251443200","authorId":"4095298251443200","name":"Jamz_stocks","avatar":"https://static.tigerbbs.com/07784544f98dce3e8324f1d04931e866","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4095298251443200","idStr":"4095298251443200"},"themes":[],"htmlText":"Knew it","listText":"Knew it","text":"Knew it","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/601141126","repostId":"1187151018","repostType":2,"repost":{"id":"1187151018","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1638499784,"share":"https://www.laohu8.com/m/news/1187151018?lang=zh_CN&edition=full","pubTime":"2021-12-03 10:49","market":"us","language":"en","title":"Elon Musk continued to sell his Tesla stocks.<blockquote>Elon Musk继续抛售特斯拉股票。</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1187151018","media":"Tiger Newspress","summary":"Elon Musk continued to sell his Tesla stocks.\nMusk sold 934,091 Tesla shares on December 2 with a to","content":"<p>Elon Musk continued to sell his Tesla stocks.</p><p><blockquote>Elon Musk继续抛售特斯拉股票。</blockquote></p><p> Musk sold 934,091 Tesla shares on December 2 with a total value of US$1.01 billion.</p><p><blockquote>马斯克在12月2日出售了934091股特斯拉股票,总价值10.1亿美元。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Elon Musk continued to sell his Tesla stocks.<blockquote>Elon Musk继续抛售特斯拉股票。</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nElon Musk continued to sell his Tesla stocks.<blockquote>Elon Musk继续抛售特斯拉股票。</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-12-03 10:49</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Elon Musk continued to sell his Tesla stocks.</p><p><blockquote>Elon Musk继续抛售特斯拉股票。</blockquote></p><p> Musk sold 934,091 Tesla shares on December 2 with a total value of US$1.01 billion.</p><p><blockquote>马斯克在12月2日出售了934091股特斯拉股票,总价值10.1亿美元。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1187151018","content_text":"Elon Musk continued to sell his Tesla stocks.\nMusk sold 934,091 Tesla shares on December 2 with a total value of US$1.01 billion.","news_type":1,"symbols_score_info":{"TSLA":0.9}},"isVote":1,"tweetType":1,"viewCount":1730,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":609754826,"gmtCreate":1638330888327,"gmtModify":1638330888389,"author":{"id":"4095298251443200","authorId":"4095298251443200","name":"Jamz_stocks","avatar":"https://static.tigerbbs.com/07784544f98dce3e8324f1d04931e866","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4095298251443200","idStr":"4095298251443200"},"themes":[],"htmlText":"Up up and up","listText":"Up up and up","text":"Up up and up","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/609754826","repostId":"1122277459","repostType":4,"repost":{"id":"1122277459","kind":"news","pubTimestamp":1638314069,"share":"https://www.laohu8.com/m/news/1122277459?lang=zh_CN&edition=full","pubTime":"2021-12-01 07:14","market":"us","language":"en","title":"GlobalFoundries forecasts upbeat sales on booming chip demand<blockquote>GlobalFoundries预测芯片需求蓬勃发展将带来乐观销售</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1122277459","media":"Reuters","summary":"GlobalFoundries(GFS.O)forecast upbeat current-quarter sales on Tuesday, in its first earnings update","content":"<p>GlobalFoundries(GFS.O)forecast upbeat current-quarter sales on Tuesday, in its first earnings update after going public in October, banking on a spike in chip demand as companies scramble to secure supplies amid a global semiconductor crunch.</p><p><blockquote>GlobalFoundries(GFS.O)周二在10月份上市后的首次财报更新中预测本季度销售乐观,预计随着全球半导体紧缩,各公司争先恐后地确保供应,芯片需求将激增。</blockquote></p><p> The Malta, New York-based company makes silicon wafers for chip designers such as Advanced Micro Devices, Broadcom Inc and Qualcomm Inc, which do not have their own fabrication plants, called fabs.</p><p><blockquote>这家总部位于纽约马耳他的公司为Advanced Micro Devices、Broadcom Inc和Qualcomm Inc等芯片设计公司生产硅片,这些公司没有自己的制造厂(称为晶圆厂)。</blockquote></p><p> Although the pandemic has fueled demand for laptops, mobile phones and cars, it has also exacerbated a worldwide shortage of semiconductor chips, forcing automakers and electronic firms to curtail production and delay rollouts of new products.</p><p><blockquote>尽管疫情刺激了对笔记本电脑、手机和汽车的需求,但也加剧了全球半导体芯片的短缺,迫使汽车制造商和电子公司削减产量并推迟新产品的推出。</blockquote></p><p> The current shortage centers around less-advanced chips used in making integrated circuits (ICs) and microcontrollers and comes as foundries such as Taiwan Semiconductor Manufacturing Co Ltd(2330.TW)shift their focus on making higher-margin, cutting-edge chips used in smart phones and laptops.</p><p><blockquote>目前的短缺主要集中在用于制造集成电路(IC)和微控制器的不太先进的芯片上,而台积电股份有限公司(2330.TW)等代工厂将重点转向制造用于制造利润更高的尖端芯片。智能手机和笔记本电脑。</blockquote></p><p> That, in turn, has helped GlobalFoundries, which is the world's third-largest foundry by revenue, to stay competitive in that segment of the market.</p><p><blockquote>这反过来又帮助全球收入第三大代工厂GlobalFoundries在该细分市场保持竞争力。</blockquote></p><p> The company forecast fourth-quarter revenue of between $1.8 billion and $1.83 billion, the low end of which was in line analyts' estimates, according to Refinitiv data.</p><p><blockquote>根据Refinitiv的数据,该公司预计第四季度营收在18亿美元至18.3亿美元之间,其低端符合line analyts的预期。</blockquote></p><p> GlobalFoundries posted revenue of $1.7 billion and a profit of 7 cents per share for the third quarter ended Sept. 30, both of which beat Wall Street's estimates.</p><p><blockquote>格芯公布截至9月30日的第三季度营收为17亿美元,每股利润为7美分,均超出华尔街预期。</blockquote></p><p> Chief Executive Officer Tom Caulfield said higher wafer output primarily drove revenue growth.</p><p><blockquote>首席执行官Tom Caulfield表示,更高的晶圆产量主要推动了收入增长。</blockquote></p><p> Still, the company's gross margins remained markedly low at about 18% in the latest quarter, compared with foundry rivals TSMC and Intel, whose gross margins came in well above 50%.</p><p><blockquote>尽管如此,该公司最近一个季度的毛利率仍明显较低,约为18%,而代工竞争对手台积电和英特尔的毛利率远高于50%。</blockquote></p><p> Shares of the company rose 1.27% in extended trading. They have risen nearly 50% since going public, valuing the company at more than $37 billion.</p><p><blockquote>该公司股价在盘后交易中上涨1.27%。自上市以来,它们已上涨近50%,公司估值超过370亿美元。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>GlobalFoundries forecasts upbeat sales on booming chip demand<blockquote>GlobalFoundries预测芯片需求蓬勃发展将带来乐观销售</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGlobalFoundries forecasts upbeat sales on booming chip demand<blockquote>GlobalFoundries预测芯片需求蓬勃发展将带来乐观销售</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Reuters</strong><span class=\"h-time small\">2021-12-01 07:14</span>\n</p>\n</h4>\n</header>\n<article>\n<p>GlobalFoundries(GFS.O)forecast upbeat current-quarter sales on Tuesday, in its first earnings update after going public in October, banking on a spike in chip demand as companies scramble to secure supplies amid a global semiconductor crunch.</p><p><blockquote>GlobalFoundries(GFS.O)周二在10月份上市后的首次财报更新中预测本季度销售乐观,预计随着全球半导体紧缩,各公司争先恐后地确保供应,芯片需求将激增。</blockquote></p><p> The Malta, New York-based company makes silicon wafers for chip designers such as Advanced Micro Devices, Broadcom Inc and Qualcomm Inc, which do not have their own fabrication plants, called fabs.</p><p><blockquote>这家总部位于纽约马耳他的公司为Advanced Micro Devices、Broadcom Inc和Qualcomm Inc等芯片设计公司生产硅片,这些公司没有自己的制造厂(称为晶圆厂)。</blockquote></p><p> Although the pandemic has fueled demand for laptops, mobile phones and cars, it has also exacerbated a worldwide shortage of semiconductor chips, forcing automakers and electronic firms to curtail production and delay rollouts of new products.</p><p><blockquote>尽管疫情刺激了对笔记本电脑、手机和汽车的需求,但也加剧了全球半导体芯片的短缺,迫使汽车制造商和电子公司削减产量并推迟新产品的推出。</blockquote></p><p> The current shortage centers around less-advanced chips used in making integrated circuits (ICs) and microcontrollers and comes as foundries such as Taiwan Semiconductor Manufacturing Co Ltd(2330.TW)shift their focus on making higher-margin, cutting-edge chips used in smart phones and laptops.</p><p><blockquote>目前的短缺主要集中在用于制造集成电路(IC)和微控制器的不太先进的芯片上,而台积电股份有限公司(2330.TW)等代工厂将重点转向制造用于制造利润更高的尖端芯片。智能手机和笔记本电脑。</blockquote></p><p> That, in turn, has helped GlobalFoundries, which is the world's third-largest foundry by revenue, to stay competitive in that segment of the market.</p><p><blockquote>这反过来又帮助全球收入第三大代工厂GlobalFoundries在该细分市场保持竞争力。</blockquote></p><p> The company forecast fourth-quarter revenue of between $1.8 billion and $1.83 billion, the low end of which was in line analyts' estimates, according to Refinitiv data.</p><p><blockquote>根据Refinitiv的数据,该公司预计第四季度营收在18亿美元至18.3亿美元之间,其低端符合line analyts的预期。</blockquote></p><p> GlobalFoundries posted revenue of $1.7 billion and a profit of 7 cents per share for the third quarter ended Sept. 30, both of which beat Wall Street's estimates.</p><p><blockquote>格芯公布截至9月30日的第三季度营收为17亿美元,每股利润为7美分,均超出华尔街预期。</blockquote></p><p> Chief Executive Officer Tom Caulfield said higher wafer output primarily drove revenue growth.</p><p><blockquote>首席执行官Tom Caulfield表示,更高的晶圆产量主要推动了收入增长。</blockquote></p><p> Still, the company's gross margins remained markedly low at about 18% in the latest quarter, compared with foundry rivals TSMC and Intel, whose gross margins came in well above 50%.</p><p><blockquote>尽管如此,该公司最近一个季度的毛利率仍明显较低,约为18%,而代工竞争对手台积电和英特尔的毛利率远高于50%。</blockquote></p><p> Shares of the company rose 1.27% in extended trading. They have risen nearly 50% since going public, valuing the company at more than $37 billion.</p><p><blockquote>该公司股价在盘后交易中上涨1.27%。自上市以来,它们已上涨近50%,公司估值超过370亿美元。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源:<a href=\"https://www.reuters.com/technology/globalfoundries-posts-56-rise-quarterly-sales-booming-chip-demand-2021-11-30/\">Reuters</a></p>\n<p>为提升您的阅读体验,我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GFS":"GLOBALFOUNDRIES Inc."},"source_url":"https://www.reuters.com/technology/globalfoundries-posts-56-rise-quarterly-sales-booming-chip-demand-2021-11-30/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1122277459","content_text":"GlobalFoundries(GFS.O)forecast upbeat current-quarter sales on Tuesday, in its first earnings update after going public in October, banking on a spike in chip demand as companies scramble to secure supplies amid a global semiconductor crunch.\nThe Malta, New York-based company makes silicon wafers for chip designers such as Advanced Micro Devices, Broadcom Inc and Qualcomm Inc, which do not have their own fabrication plants, called fabs.\nAlthough the pandemic has fueled demand for laptops, mobile phones and cars, it has also exacerbated a worldwide shortage of semiconductor chips, forcing automakers and electronic firms to curtail production and delay rollouts of new products.\nThe current shortage centers around less-advanced chips used in making integrated circuits (ICs) and microcontrollers and comes as foundries such as Taiwan Semiconductor Manufacturing Co Ltd(2330.TW)shift their focus on making higher-margin, cutting-edge chips used in smart phones and laptops.\nThat, in turn, has helped GlobalFoundries, which is the world's third-largest foundry by revenue, to stay competitive in that segment of the market.\nThe company forecast fourth-quarter revenue of between $1.8 billion and $1.83 billion, the low end of which was in line analyts' estimates, according to Refinitiv data.\nGlobalFoundries posted revenue of $1.7 billion and a profit of 7 cents per share for the third quarter ended Sept. 30, both of which beat Wall Street's estimates.\nChief Executive Officer Tom Caulfield said higher wafer output primarily drove revenue growth.\nStill, the company's gross margins remained markedly low at about 18% in the latest quarter, compared with foundry rivals TSMC and Intel, whose gross margins came in well above 50%.\nShares of the company rose 1.27% in extended trading. They have risen nearly 50% since going public, valuing the company at more than $37 billion.","news_type":1,"symbols_score_info":{"GFS":0.9}},"isVote":1,"tweetType":1,"viewCount":2115,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":875767918,"gmtCreate":1637696039306,"gmtModify":1637696039385,"author":{"id":"4095298251443200","authorId":"4095298251443200","name":"Jamz_stocks","avatar":"https://static.tigerbbs.com/07784544f98dce3e8324f1d04931e866","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4095298251443200","idStr":"4095298251443200"},"themes":[],"htmlText":"It will go bacn up","listText":"It will go bacn up","text":"It will go bacn up","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/875767918","repostId":"2185848553","repostType":4,"isVote":1,"tweetType":1,"viewCount":2098,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"hots":[{"id":601757024,"gmtCreate":1638575271804,"gmtModify":1638575271804,"author":{"id":"4095298251443200","authorId":"4095298251443200","name":"Jamz_stocks","avatar":"https://static.tigerbbs.com/07784544f98dce3e8324f1d04931e866","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4095298251443200","idStr":"4095298251443200"},"themes":[],"htmlText":"3rd time in a row.. he sells whenever i buy","listText":"3rd time in a row.. he sells whenever i buy","text":"3rd time in a row.. he sells whenever i buy","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/601757024","repostId":"1158981658","repostType":4,"isVote":1,"tweetType":1,"viewCount":2266,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":699708064,"gmtCreate":1639886513443,"gmtModify":1639886513544,"author":{"id":"4095298251443200","authorId":"4095298251443200","name":"Jamz_stocks","avatar":"https://static.tigerbbs.com/07784544f98dce3e8324f1d04931e866","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4095298251443200","idStr":"4095298251443200"},"themes":[],"htmlText":"Fly","listText":"Fly","text":"Fly","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/699708064","repostId":"1122414343","repostType":4,"repost":{"id":"1122414343","kind":"news","pubTimestamp":1639884070,"share":"https://www.laohu8.com/m/news/1122414343?lang=zh_CN&edition=full","pubTime":"2021-12-19 11:21","market":"us","language":"en","title":"Novavax, Vir among healthcare gainers, Pfizer posts best rally in a decade<blockquote>Novavax、Vir跻身医疗保健股涨幅之列,辉瑞(Pfizer)创下十年来最佳涨幅</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1122414343","media":"Seeking Alpha","summary":"The healthcare stocks in the S&P 500 outperformed all other sectors in the broader index with a ~2.5","content":"<p>The healthcare stocks in the S&P 500 outperformed all other sectors in the broader index with a ~2.5% gain thanks mainly to M&A prospects. <a href=\"https://laohu8.com/S/HCSG\">Healthcare</a> technology, along with names battling the resurgence of COVID-19, led the gainers while the overall index fell ~1.9%.</p><p><blockquote>标普500的医疗保健股表现优于大盘指数中的所有其他板块,涨幅约为2.5%,主要得益于并购前景。<a href=\"https://laohu8.com/S/HCSG\">医疗保健</a>科技股以及与COVID-19死灰复燃作斗争的股票领涨,而整体指数下跌约1.9%。</blockquote></p><p> Among stocks with more than $2B market capitalization and 100K average daily volume over the past week, <a href=\"https://laohu8.com/S/ARNA\">Arena Pharmaceuticals </a> dominated with a ~83.8% rise after <a href=\"https://laohu8.com/S/PFE\">Pfizer </a> agreed to acquire it in a ~$6.7B deal with 100% premium for the biotech. <a href=\"https://laohu8.com/S/CERN\">Cerner </a> also joined the M&A-driven rally to gain ~20.7% over the week amid reports of a potential ~$30B bid from <a href=\"https://laohu8.com/S/ORCL\">Oracle </a> for the electronic-medical-records company.</p><p><blockquote>在过去一周市值超过20亿美元、日均成交量超过10万的股票中,<a href=\"https://laohu8.com/S/ARNA\">Arena制药公司</a>之后上涨约83.8%<a href=\"https://laohu8.com/S/PFE\">辉瑞</a>同意以约6.7 B美元的价格收购该生物技术公司,溢价100%。<a href=\"https://laohu8.com/S/CERN\">塞尔纳</a>也加入了并购推动的涨势,本周上涨约20.7%,有报道称来自<a href=\"https://laohu8.com/S/ORCL\">神谕</a>电子病历公司。</blockquote></p><p> Vaccine developer, <a href=\"https://laohu8.com/S/NVAX\">Novavax </a> jumped ~30.5% as investors welcomed the WHO clearance for the company’s COVID-19 shot. Further gains for the Maryland-based biotech are likely when an expert panel of the European regulators is set to review the marketing authorization for the vaccine next week.</p><p><blockquote>疫苗开发商、<a href=\"https://laohu8.com/S/NVAX\">Novavax</a>由于投资者欢迎世界卫生组织批准该公司的COVID-19疫苗,股价上涨约30.5%。当欧洲监管机构的专家小组将于下周审查该疫苗的营销授权时,这家总部位于马里兰州的生物技术公司可能会进一步受益。</blockquote></p><p> <a href=\"https://laohu8.com/S/BHVN\">Biohaven Pharmaceutical </a> posted a ~25.2% weekly rise after the company announced the approval for NURTEC ODT (rimegepant) in Israel, making it the first regulatory win for the migraine drug outside the U.S. Meanwhile, Vir Biotechnology (NASDAQ:VIR) surged ~23.7% to stand among best gainers for the second week this month. More data emerged this week confirming the Omicron-neutralizing effect of the company’s COVID-19 therapy developed in partnership with GlaxoSmithKline (NYSE:GSK). Rounding out the top five gainers, <a href=\"https://laohu8.com/S/ROIV\">Roivant Sciences </a> added ~22.6%.</p><p><blockquote><a href=\"https://laohu8.com/S/BHVN\">Biohaven制药</a>在该公司宣布NURTEC ODT(rimegepant)在以色列获得批准后,该公司每周上涨约25.2%,使其成为该偏头痛药物在美国以外的首个监管胜利。与此同时,Vir Biotechnology(纳斯达克股票代码:VIR)飙升约23.7%,成为本月第二周涨幅最大的股票之一。本周出现的更多数据证实了该公司与葛兰素史克(纽约证券交易所股票代码:GSK)合作开发的COVID-19疗法具有奥密克戎中和作用。跻身涨幅前五名的还有,<a href=\"https://laohu8.com/S/ROIV\">Roivant科学</a>增加了约22.6%。</blockquote></p><p> Notable gainer: <a href=\"https://laohu8.com/S/PFE\">Pfizer</a> (PFE) made headlines throughout the week, raising its sales guidance for the COVID-19 vaccine once again as the rapidly spreading Omicron variant highlighted the need for booster shots. Despite an abrupt end to its six-day rally on Friday, the <a href=\"https://laohu8.com/S/NWY\">New York</a>-based pharma giant with a ~12.7% rise recorded its best weekly gain since March 2009.</p><p><blockquote>值得注意的赢家:<a href=\"https://laohu8.com/S/PFE\">辉瑞</a>(PFE)本周成为头条新闻,再次提高了COVID-19疫苗的销售指引,因为迅速传播的奥密克戎变种凸显了加强注射的必要性。尽管周五突然结束了连续六天的涨势,<a href=\"https://laohu8.com/S/NWY\">纽约</a>总部位于美国的制药巨头股价上涨约12.7%,创下2009年3月以来的最佳单周涨幅。</blockquote></p><p> Among worst performers of the week, two newly IPO’ed biotechs, Instil Bio (NASDAQ:TIL) and Exscientia (NASDAQ:EXAI), stood out, falling 19.3% and ~13.5%, respectively, despite their favorable ratings on Wall Street. Meanwhile, GoodRx Holdings (NASDAQ:GDRX), an operator of a price comparison platform for prescription medicine slumped ~15.6%.</p><p><blockquote>在本周表现最差的公司中,两家新IPO的生物技术公司Instil Bio(纳斯达克股票代码:TIL)和Exscientia(纳斯达克股票代码:EXAI)脱颖而出,尽管它们在华尔街获得了良好的评级,但分别下跌了19.3%和约13.5%。与此同时,处方药比价平台运营商GoodRx Holdings(纳斯达克股票代码:GDRX)股价下跌约15.6%。</blockquote></p><p> Last week’s best performer, <a href=\"https://laohu8.com/S/BHG\">Bright Health Group</a>, crashed ~13.1%, hurt by the sole Sell rating issued by <a href=\"https://laohu8.com/S/GS\">Goldman Sachs</a> even as the investment bank kicked off its coverage on managed care with largely positive views.</p><p><blockquote>上周表现最好的,<a href=\"https://laohu8.com/S/BHG\">光明健康集团</a>,暴跌约13.1%,受到唯一卖出评级的伤害<a href=\"https://laohu8.com/S/GS\">高盛</a>尽管这家投资银行以基本积极的观点开始了对管理式医疗的报道。</blockquote></p><p> Allogene Therapeutics (NASDAQ:ALLO) dropped ~12.3% after the company’s ASH presentations on Phase 1 data for experimental allogeneic <a href=\"https://laohu8.com/S/00699\">CAR</a> T therapies failed to excite investors, including Cathie Wood’s Ark Investment Management, which sold ~1.6M shares of the biotech several days later.</p><p><blockquote>Allogene Therapeutics(纳斯达克股票代码:ALLO)在ASH介绍实验性同种异体药物1期数据后股价下跌约12.3%<a href=\"https://laohu8.com/S/00699\">车</a>T疗法未能让投资者兴奋,其中包括Cathie Wood的Ark Investment Management,该公司几天后出售了约160万股该生物技术公司的股票。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Novavax, Vir among healthcare gainers, Pfizer posts best rally in a decade<blockquote>Novavax、Vir跻身医疗保健股涨幅之列,辉瑞(Pfizer)创下十年来最佳涨幅</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovavax, Vir among healthcare gainers, Pfizer posts best rally in a decade<blockquote>Novavax、Vir跻身医疗保健股涨幅之列,辉瑞(Pfizer)创下十年来最佳涨幅</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Seeking Alpha</strong><span class=\"h-time small\">2021-12-19 11:21</span>\n</p>\n</h4>\n</header>\n<article>\n<p>The healthcare stocks in the S&P 500 outperformed all other sectors in the broader index with a ~2.5% gain thanks mainly to M&A prospects. <a href=\"https://laohu8.com/S/HCSG\">Healthcare</a> technology, along with names battling the resurgence of COVID-19, led the gainers while the overall index fell ~1.9%.</p><p><blockquote>标普500的医疗保健股表现优于大盘指数中的所有其他板块,涨幅约为2.5%,主要得益于并购前景。<a href=\"https://laohu8.com/S/HCSG\">医疗保健</a>科技股以及与COVID-19死灰复燃作斗争的股票领涨,而整体指数下跌约1.9%。</blockquote></p><p> Among stocks with more than $2B market capitalization and 100K average daily volume over the past week, <a href=\"https://laohu8.com/S/ARNA\">Arena Pharmaceuticals </a> dominated with a ~83.8% rise after <a href=\"https://laohu8.com/S/PFE\">Pfizer </a> agreed to acquire it in a ~$6.7B deal with 100% premium for the biotech. <a href=\"https://laohu8.com/S/CERN\">Cerner </a> also joined the M&A-driven rally to gain ~20.7% over the week amid reports of a potential ~$30B bid from <a href=\"https://laohu8.com/S/ORCL\">Oracle </a> for the electronic-medical-records company.</p><p><blockquote>在过去一周市值超过20亿美元、日均成交量超过10万的股票中,<a href=\"https://laohu8.com/S/ARNA\">Arena制药公司</a>之后上涨约83.8%<a href=\"https://laohu8.com/S/PFE\">辉瑞</a>同意以约6.7 B美元的价格收购该生物技术公司,溢价100%。<a href=\"https://laohu8.com/S/CERN\">塞尔纳</a>也加入了并购推动的涨势,本周上涨约20.7%,有报道称来自<a href=\"https://laohu8.com/S/ORCL\">神谕</a>电子病历公司。</blockquote></p><p> Vaccine developer, <a href=\"https://laohu8.com/S/NVAX\">Novavax </a> jumped ~30.5% as investors welcomed the WHO clearance for the company’s COVID-19 shot. Further gains for the Maryland-based biotech are likely when an expert panel of the European regulators is set to review the marketing authorization for the vaccine next week.</p><p><blockquote>疫苗开发商、<a href=\"https://laohu8.com/S/NVAX\">Novavax</a>由于投资者欢迎世界卫生组织批准该公司的COVID-19疫苗,股价上涨约30.5%。当欧洲监管机构的专家小组将于下周审查该疫苗的营销授权时,这家总部位于马里兰州的生物技术公司可能会进一步受益。</blockquote></p><p> <a href=\"https://laohu8.com/S/BHVN\">Biohaven Pharmaceutical </a> posted a ~25.2% weekly rise after the company announced the approval for NURTEC ODT (rimegepant) in Israel, making it the first regulatory win for the migraine drug outside the U.S. Meanwhile, Vir Biotechnology (NASDAQ:VIR) surged ~23.7% to stand among best gainers for the second week this month. More data emerged this week confirming the Omicron-neutralizing effect of the company’s COVID-19 therapy developed in partnership with GlaxoSmithKline (NYSE:GSK). Rounding out the top five gainers, <a href=\"https://laohu8.com/S/ROIV\">Roivant Sciences </a> added ~22.6%.</p><p><blockquote><a href=\"https://laohu8.com/S/BHVN\">Biohaven制药</a>在该公司宣布NURTEC ODT(rimegepant)在以色列获得批准后,该公司每周上涨约25.2%,使其成为该偏头痛药物在美国以外的首个监管胜利。与此同时,Vir Biotechnology(纳斯达克股票代码:VIR)飙升约23.7%,成为本月第二周涨幅最大的股票之一。本周出现的更多数据证实了该公司与葛兰素史克(纽约证券交易所股票代码:GSK)合作开发的COVID-19疗法具有奥密克戎中和作用。跻身涨幅前五名的还有,<a href=\"https://laohu8.com/S/ROIV\">Roivant科学</a>增加了约22.6%。</blockquote></p><p> Notable gainer: <a href=\"https://laohu8.com/S/PFE\">Pfizer</a> (PFE) made headlines throughout the week, raising its sales guidance for the COVID-19 vaccine once again as the rapidly spreading Omicron variant highlighted the need for booster shots. Despite an abrupt end to its six-day rally on Friday, the <a href=\"https://laohu8.com/S/NWY\">New York</a>-based pharma giant with a ~12.7% rise recorded its best weekly gain since March 2009.</p><p><blockquote>值得注意的赢家:<a href=\"https://laohu8.com/S/PFE\">辉瑞</a>(PFE)本周成为头条新闻,再次提高了COVID-19疫苗的销售指引,因为迅速传播的奥密克戎变种凸显了加强注射的必要性。尽管周五突然结束了连续六天的涨势,<a href=\"https://laohu8.com/S/NWY\">纽约</a>总部位于美国的制药巨头股价上涨约12.7%,创下2009年3月以来的最佳单周涨幅。</blockquote></p><p> Among worst performers of the week, two newly IPO’ed biotechs, Instil Bio (NASDAQ:TIL) and Exscientia (NASDAQ:EXAI), stood out, falling 19.3% and ~13.5%, respectively, despite their favorable ratings on Wall Street. Meanwhile, GoodRx Holdings (NASDAQ:GDRX), an operator of a price comparison platform for prescription medicine slumped ~15.6%.</p><p><blockquote>在本周表现最差的公司中,两家新IPO的生物技术公司Instil Bio(纳斯达克股票代码:TIL)和Exscientia(纳斯达克股票代码:EXAI)脱颖而出,尽管它们在华尔街获得了良好的评级,但分别下跌了19.3%和约13.5%。与此同时,处方药比价平台运营商GoodRx Holdings(纳斯达克股票代码:GDRX)股价下跌约15.6%。</blockquote></p><p> Last week’s best performer, <a href=\"https://laohu8.com/S/BHG\">Bright Health Group</a>, crashed ~13.1%, hurt by the sole Sell rating issued by <a href=\"https://laohu8.com/S/GS\">Goldman Sachs</a> even as the investment bank kicked off its coverage on managed care with largely positive views.</p><p><blockquote>上周表现最好的,<a href=\"https://laohu8.com/S/BHG\">光明健康集团</a>,暴跌约13.1%,受到唯一卖出评级的伤害<a href=\"https://laohu8.com/S/GS\">高盛</a>尽管这家投资银行以基本积极的观点开始了对管理式医疗的报道。</blockquote></p><p> Allogene Therapeutics (NASDAQ:ALLO) dropped ~12.3% after the company’s ASH presentations on Phase 1 data for experimental allogeneic <a href=\"https://laohu8.com/S/00699\">CAR</a> T therapies failed to excite investors, including Cathie Wood’s Ark Investment Management, which sold ~1.6M shares of the biotech several days later.</p><p><blockquote>Allogene Therapeutics(纳斯达克股票代码:ALLO)在ASH介绍实验性同种异体药物1期数据后股价下跌约12.3%<a href=\"https://laohu8.com/S/00699\">车</a>T疗法未能让投资者兴奋,其中包括Cathie Wood的Ark Investment Management,该公司几天后出售了约160万股该生物技术公司的股票。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源:<a href=\"https://seekingalpha.com/news/3781487-novavax-vir-among-healthcare-gainers-pfizer-posts-best-rally-in-a-decade\">Seeking Alpha</a></p>\n<p>为提升您的阅读体验,我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4533":"AQR资本管理(全球第二大对冲基金)","BK4007":"制药","BK4568":"美国抗疫概念","PFE":"辉瑞","CERN":"美国塞纳","BK4550":"红杉资本持仓","BK4534":"瑞士信贷持仓","ORCL":"甲骨文","ARNA":"阿里那"},"source_url":"https://seekingalpha.com/news/3781487-novavax-vir-among-healthcare-gainers-pfizer-posts-best-rally-in-a-decade","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1122414343","content_text":"The healthcare stocks in the S&P 500 outperformed all other sectors in the broader index with a ~2.5% gain thanks mainly to M&A prospects. Healthcare technology, along with names battling the resurgence of COVID-19, led the gainers while the overall index fell ~1.9%.\nAmong stocks with more than $2B market capitalization and 100K average daily volume over the past week, Arena Pharmaceuticals dominated with a ~83.8% rise after Pfizer agreed to acquire it in a ~$6.7B deal with 100% premium for the biotech. Cerner also joined the M&A-driven rally to gain ~20.7% over the week amid reports of a potential ~$30B bid from Oracle for the electronic-medical-records company.\nVaccine developer, Novavax jumped ~30.5% as investors welcomed the WHO clearance for the company’s COVID-19 shot. Further gains for the Maryland-based biotech are likely when an expert panel of the European regulators is set to review the marketing authorization for the vaccine next week.\nBiohaven Pharmaceutical posted a ~25.2% weekly rise after the company announced the approval for NURTEC ODT (rimegepant) in Israel, making it the first regulatory win for the migraine drug outside the U.S. Meanwhile, Vir Biotechnology (NASDAQ:VIR) surged ~23.7% to stand among best gainers for the second week this month. More data emerged this week confirming the Omicron-neutralizing effect of the company’s COVID-19 therapy developed in partnership with GlaxoSmithKline (NYSE:GSK). Rounding out the top five gainers, Roivant Sciences added ~22.6%.\nNotable gainer: Pfizer (PFE) made headlines throughout the week, raising its sales guidance for the COVID-19 vaccine once again as the rapidly spreading Omicron variant highlighted the need for booster shots. Despite an abrupt end to its six-day rally on Friday, the New York-based pharma giant with a ~12.7% rise recorded its best weekly gain since March 2009.\nAmong worst performers of the week, two newly IPO’ed biotechs, Instil Bio (NASDAQ:TIL) and Exscientia (NASDAQ:EXAI), stood out, falling 19.3% and ~13.5%, respectively, despite their favorable ratings on Wall Street. Meanwhile, GoodRx Holdings (NASDAQ:GDRX), an operator of a price comparison platform for prescription medicine slumped ~15.6%.\nLast week’s best performer, Bright Health Group, crashed ~13.1%, hurt by the sole Sell rating issued by Goldman Sachs even as the investment bank kicked off its coverage on managed care with largely positive views.\nAllogene Therapeutics (NASDAQ:ALLO) dropped ~12.3% after the company’s ASH presentations on Phase 1 data for experimental allogeneic CAR T therapies failed to excite investors, including Cathie Wood’s Ark Investment Management, which sold ~1.6M shares of the biotech several days later.","news_type":1,"symbols_score_info":{"ARNA":0.9,"ORCL":0.9,"CERN":0.9,"PFE":0.9}},"isVote":1,"tweetType":1,"viewCount":4137,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":601141126,"gmtCreate":1638501348367,"gmtModify":1638501348367,"author":{"id":"4095298251443200","authorId":"4095298251443200","name":"Jamz_stocks","avatar":"https://static.tigerbbs.com/07784544f98dce3e8324f1d04931e866","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4095298251443200","idStr":"4095298251443200"},"themes":[],"htmlText":"Knew it","listText":"Knew it","text":"Knew it","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/601141126","repostId":"1187151018","repostType":2,"repost":{"id":"1187151018","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1638499784,"share":"https://www.laohu8.com/m/news/1187151018?lang=zh_CN&edition=full","pubTime":"2021-12-03 10:49","market":"us","language":"en","title":"Elon Musk continued to sell his Tesla stocks.<blockquote>Elon Musk继续抛售特斯拉股票。</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1187151018","media":"Tiger Newspress","summary":"Elon Musk continued to sell his Tesla stocks.\nMusk sold 934,091 Tesla shares on December 2 with a to","content":"<p>Elon Musk continued to sell his Tesla stocks.</p><p><blockquote>Elon Musk继续抛售特斯拉股票。</blockquote></p><p> Musk sold 934,091 Tesla shares on December 2 with a total value of US$1.01 billion.</p><p><blockquote>马斯克在12月2日出售了934091股特斯拉股票,总价值10.1亿美元。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Elon Musk continued to sell his Tesla stocks.<blockquote>Elon Musk继续抛售特斯拉股票。</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nElon Musk continued to sell his Tesla stocks.<blockquote>Elon Musk继续抛售特斯拉股票。</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-12-03 10:49</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Elon Musk continued to sell his Tesla stocks.</p><p><blockquote>Elon Musk继续抛售特斯拉股票。</blockquote></p><p> Musk sold 934,091 Tesla shares on December 2 with a total value of US$1.01 billion.</p><p><blockquote>马斯克在12月2日出售了934091股特斯拉股票,总价值10.1亿美元。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1187151018","content_text":"Elon Musk continued to sell his Tesla stocks.\nMusk sold 934,091 Tesla shares on December 2 with a total value of US$1.01 billion.","news_type":1,"symbols_score_info":{"TSLA":0.9}},"isVote":1,"tweetType":1,"viewCount":1730,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":607395041,"gmtCreate":1639486073837,"gmtModify":1639486073932,"author":{"id":"4095298251443200","authorId":"4095298251443200","name":"Jamz_stocks","avatar":"https://static.tigerbbs.com/07784544f98dce3e8324f1d04931e866","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4095298251443200","idStr":"4095298251443200"},"themes":[],"htmlText":"looks like he's the one buying the dip","listText":"looks like he's the one buying the dip","text":"looks like he's the one buying the dip","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/607395041","repostId":"1166550850","repostType":4,"repost":{"id":"1166550850","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1639473176,"share":"https://www.laohu8.com/m/news/1166550850?lang=zh_CN&edition=full","pubTime":"2021-12-14 17:12","market":"us","language":"en","title":"Tesla dipped nearly 2% in premarket trading as Musk sold another 934,091 shares on Monday<blockquote>特斯拉在盘前交易中下跌近2%,马斯克周一又出售了934,091股</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1166550850","media":"Tiger Newspress","summary":"Tesla dipped nearly 2% in premarket trading as Musk sold another 934,091 shares on Monday.Tesla CEO Elon Musk sold another 934,091 shares in the automaker, worth nearly $906.5 million, on Monday, as per filings made with the U.S. Securities and Exchange Commission.Musk conducted the sale of shares to satisfy tax withholding obligations on the exercise of stock options to purchase 2.13 million shares of Tesla, as per the filings.Musk has sold 12 million shares since he tweeted on November 6 that ","content":"<p>Tesla dipped nearly 2% in premarket trading as Musk sold another 934,091 shares on Monday.<img src=\"https://static.tigerbbs.com/19cc3dded28a854d32d0ca0677db7efc\" tg-width=\"773\" tg-height=\"567\" width=\"100%\" height=\"auto\">Tesla CEO Elon Musk sold another 934,091 shares in the automaker, worth nearly $906.5 million, on Monday, as per filings made with the U.S. Securities and Exchange Commission.</p><p><blockquote>由于马斯克周一又出售了934,091股,特斯拉在盘前交易中下跌近2%。根据向美国证券交易委员会提交的文件,特斯拉首席执行官Elon Musk周一又出售了934,091股该汽车制造商的股票,价值近9.065亿美元。</blockquote></p><p> Musk conducted the sale of shares to satisfy tax withholding obligations on the exercise of stock options to purchase 2.13 million shares of Tesla, as per the filings.</p><p><blockquote>文件显示,马斯克出售股票是为了履行行使股票期权购买213万股特斯拉股票时的预扣税义务。</blockquote></p><p> Musk has sold 12 million shares since he tweeted on November 6 that he would reduce his stake in Tesla Motors by 10%.</p><p><blockquote>自11月6日马斯克发推表示将减持10%的特斯拉股份以来,马斯克已经卖出了1200万股。</blockquote></p><p> If you don't count the stocks he bought, the number of shares reduced has actually reached the goal that10% of the shares sold is equivalent to about 17 million shares.</p><p><blockquote>如果不算他买入的股票,减持的股票数量实际上已经达到了卖出股票的10%相当于1700万股左右的目标。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tesla dipped nearly 2% in premarket trading as Musk sold another 934,091 shares on Monday<blockquote>特斯拉在盘前交易中下跌近2%,马斯克周一又出售了934,091股</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTesla dipped nearly 2% in premarket trading as Musk sold another 934,091 shares on Monday<blockquote>特斯拉在盘前交易中下跌近2%,马斯克周一又出售了934,091股</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-12-14 17:12</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Tesla dipped nearly 2% in premarket trading as Musk sold another 934,091 shares on Monday.<img src=\"https://static.tigerbbs.com/19cc3dded28a854d32d0ca0677db7efc\" tg-width=\"773\" tg-height=\"567\" width=\"100%\" height=\"auto\">Tesla CEO Elon Musk sold another 934,091 shares in the automaker, worth nearly $906.5 million, on Monday, as per filings made with the U.S. Securities and Exchange Commission.</p><p><blockquote>由于马斯克周一又出售了934,091股,特斯拉在盘前交易中下跌近2%。根据向美国证券交易委员会提交的文件,特斯拉首席执行官Elon Musk周一又出售了934,091股该汽车制造商的股票,价值近9.065亿美元。</blockquote></p><p> Musk conducted the sale of shares to satisfy tax withholding obligations on the exercise of stock options to purchase 2.13 million shares of Tesla, as per the filings.</p><p><blockquote>文件显示,马斯克出售股票是为了履行行使股票期权购买213万股特斯拉股票时的预扣税义务。</blockquote></p><p> Musk has sold 12 million shares since he tweeted on November 6 that he would reduce his stake in Tesla Motors by 10%.</p><p><blockquote>自11月6日马斯克发推表示将减持10%的特斯拉股份以来,马斯克已经卖出了1200万股。</blockquote></p><p> If you don't count the stocks he bought, the number of shares reduced has actually reached the goal that10% of the shares sold is equivalent to about 17 million shares.</p><p><blockquote>如果不算他买入的股票,减持的股票数量实际上已经达到了卖出股票的10%相当于1700万股左右的目标。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1166550850","content_text":"Tesla dipped nearly 2% in premarket trading as Musk sold another 934,091 shares on Monday.Tesla CEO Elon Musk sold another 934,091 shares in the automaker, worth nearly $906.5 million, on Monday, as per filings made with the U.S. Securities and Exchange Commission.\nMusk conducted the sale of shares to satisfy tax withholding obligations on the exercise of stock options to purchase 2.13 million shares of Tesla, as per the filings.\nMusk has sold 12 million shares since he tweeted on November 6 that he would reduce his stake in Tesla Motors by 10%.\nIf you don't count the stocks he bought, the number of shares reduced has actually reached the goal that10% of the shares sold is equivalent to about 17 million shares.","news_type":1,"symbols_score_info":{"TSLA":0.9}},"isVote":1,"tweetType":1,"viewCount":1854,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":605306055,"gmtCreate":1639107989573,"gmtModify":1639108507664,"author":{"id":"4095298251443200","authorId":"4095298251443200","name":"Jamz_stocks","avatar":"https://static.tigerbbs.com/07784544f98dce3e8324f1d04931e866","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4095298251443200","idStr":"4095298251443200"},"themes":[],"htmlText":"What the heck is exercising options","listText":"What the heck is exercising options","text":"What the heck is exercising options","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/605306055","repostId":"2190641206","repostType":4,"isVote":1,"tweetType":1,"viewCount":2032,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":875767918,"gmtCreate":1637696039306,"gmtModify":1637696039385,"author":{"id":"4095298251443200","authorId":"4095298251443200","name":"Jamz_stocks","avatar":"https://static.tigerbbs.com/07784544f98dce3e8324f1d04931e866","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4095298251443200","idStr":"4095298251443200"},"themes":[],"htmlText":"It will go bacn up","listText":"It will go bacn up","text":"It will go bacn up","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/875767918","repostId":"2185848553","repostType":4,"isVote":1,"tweetType":1,"viewCount":2098,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":607394909,"gmtCreate":1639486137299,"gmtModify":1639486137364,"author":{"id":"4095298251443200","authorId":"4095298251443200","name":"Jamz_stocks","avatar":"https://static.tigerbbs.com/07784544f98dce3e8324f1d04931e866","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4095298251443200","idStr":"4095298251443200"},"themes":[],"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/607394909","repostId":"1174676939","repostType":4,"isVote":1,"tweetType":1,"viewCount":2172,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":604023518,"gmtCreate":1639284670054,"gmtModify":1639298218902,"author":{"id":"4095298251443200","authorId":"4095298251443200","name":"Jamz_stocks","avatar":"https://static.tigerbbs.com/07784544f98dce3e8324f1d04931e866","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4095298251443200","idStr":"4095298251443200"},"themes":[],"htmlText":"Bold of you to assume I’ve 100000","listText":"Bold of you to assume I’ve 100000","text":"Bold of you to assume I’ve 100000","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/604023518","repostId":"2190679207","repostType":4,"isVote":1,"tweetType":1,"viewCount":1877,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":609754826,"gmtCreate":1638330888327,"gmtModify":1638330888389,"author":{"id":"4095298251443200","authorId":"4095298251443200","name":"Jamz_stocks","avatar":"https://static.tigerbbs.com/07784544f98dce3e8324f1d04931e866","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4095298251443200","idStr":"4095298251443200"},"themes":[],"htmlText":"Up up and up","listText":"Up up and up","text":"Up up and up","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/609754826","repostId":"1122277459","repostType":4,"repost":{"id":"1122277459","kind":"news","pubTimestamp":1638314069,"share":"https://www.laohu8.com/m/news/1122277459?lang=zh_CN&edition=full","pubTime":"2021-12-01 07:14","market":"us","language":"en","title":"GlobalFoundries forecasts upbeat sales on booming chip demand<blockquote>GlobalFoundries预测芯片需求蓬勃发展将带来乐观销售</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1122277459","media":"Reuters","summary":"GlobalFoundries(GFS.O)forecast upbeat current-quarter sales on Tuesday, in its first earnings update","content":"<p>GlobalFoundries(GFS.O)forecast upbeat current-quarter sales on Tuesday, in its first earnings update after going public in October, banking on a spike in chip demand as companies scramble to secure supplies amid a global semiconductor crunch.</p><p><blockquote>GlobalFoundries(GFS.O)周二在10月份上市后的首次财报更新中预测本季度销售乐观,预计随着全球半导体紧缩,各公司争先恐后地确保供应,芯片需求将激增。</blockquote></p><p> The Malta, New York-based company makes silicon wafers for chip designers such as Advanced Micro Devices, Broadcom Inc and Qualcomm Inc, which do not have their own fabrication plants, called fabs.</p><p><blockquote>这家总部位于纽约马耳他的公司为Advanced Micro Devices、Broadcom Inc和Qualcomm Inc等芯片设计公司生产硅片,这些公司没有自己的制造厂(称为晶圆厂)。</blockquote></p><p> Although the pandemic has fueled demand for laptops, mobile phones and cars, it has also exacerbated a worldwide shortage of semiconductor chips, forcing automakers and electronic firms to curtail production and delay rollouts of new products.</p><p><blockquote>尽管疫情刺激了对笔记本电脑、手机和汽车的需求,但也加剧了全球半导体芯片的短缺,迫使汽车制造商和电子公司削减产量并推迟新产品的推出。</blockquote></p><p> The current shortage centers around less-advanced chips used in making integrated circuits (ICs) and microcontrollers and comes as foundries such as Taiwan Semiconductor Manufacturing Co Ltd(2330.TW)shift their focus on making higher-margin, cutting-edge chips used in smart phones and laptops.</p><p><blockquote>目前的短缺主要集中在用于制造集成电路(IC)和微控制器的不太先进的芯片上,而台积电股份有限公司(2330.TW)等代工厂将重点转向制造用于制造利润更高的尖端芯片。智能手机和笔记本电脑。</blockquote></p><p> That, in turn, has helped GlobalFoundries, which is the world's third-largest foundry by revenue, to stay competitive in that segment of the market.</p><p><blockquote>这反过来又帮助全球收入第三大代工厂GlobalFoundries在该细分市场保持竞争力。</blockquote></p><p> The company forecast fourth-quarter revenue of between $1.8 billion and $1.83 billion, the low end of which was in line analyts' estimates, according to Refinitiv data.</p><p><blockquote>根据Refinitiv的数据,该公司预计第四季度营收在18亿美元至18.3亿美元之间,其低端符合line analyts的预期。</blockquote></p><p> GlobalFoundries posted revenue of $1.7 billion and a profit of 7 cents per share for the third quarter ended Sept. 30, both of which beat Wall Street's estimates.</p><p><blockquote>格芯公布截至9月30日的第三季度营收为17亿美元,每股利润为7美分,均超出华尔街预期。</blockquote></p><p> Chief Executive Officer Tom Caulfield said higher wafer output primarily drove revenue growth.</p><p><blockquote>首席执行官Tom Caulfield表示,更高的晶圆产量主要推动了收入增长。</blockquote></p><p> Still, the company's gross margins remained markedly low at about 18% in the latest quarter, compared with foundry rivals TSMC and Intel, whose gross margins came in well above 50%.</p><p><blockquote>尽管如此,该公司最近一个季度的毛利率仍明显较低,约为18%,而代工竞争对手台积电和英特尔的毛利率远高于50%。</blockquote></p><p> Shares of the company rose 1.27% in extended trading. They have risen nearly 50% since going public, valuing the company at more than $37 billion.</p><p><blockquote>该公司股价在盘后交易中上涨1.27%。自上市以来,它们已上涨近50%,公司估值超过370亿美元。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>GlobalFoundries forecasts upbeat sales on booming chip demand<blockquote>GlobalFoundries预测芯片需求蓬勃发展将带来乐观销售</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGlobalFoundries forecasts upbeat sales on booming chip demand<blockquote>GlobalFoundries预测芯片需求蓬勃发展将带来乐观销售</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Reuters</strong><span class=\"h-time small\">2021-12-01 07:14</span>\n</p>\n</h4>\n</header>\n<article>\n<p>GlobalFoundries(GFS.O)forecast upbeat current-quarter sales on Tuesday, in its first earnings update after going public in October, banking on a spike in chip demand as companies scramble to secure supplies amid a global semiconductor crunch.</p><p><blockquote>GlobalFoundries(GFS.O)周二在10月份上市后的首次财报更新中预测本季度销售乐观,预计随着全球半导体紧缩,各公司争先恐后地确保供应,芯片需求将激增。</blockquote></p><p> The Malta, New York-based company makes silicon wafers for chip designers such as Advanced Micro Devices, Broadcom Inc and Qualcomm Inc, which do not have their own fabrication plants, called fabs.</p><p><blockquote>这家总部位于纽约马耳他的公司为Advanced Micro Devices、Broadcom Inc和Qualcomm Inc等芯片设计公司生产硅片,这些公司没有自己的制造厂(称为晶圆厂)。</blockquote></p><p> Although the pandemic has fueled demand for laptops, mobile phones and cars, it has also exacerbated a worldwide shortage of semiconductor chips, forcing automakers and electronic firms to curtail production and delay rollouts of new products.</p><p><blockquote>尽管疫情刺激了对笔记本电脑、手机和汽车的需求,但也加剧了全球半导体芯片的短缺,迫使汽车制造商和电子公司削减产量并推迟新产品的推出。</blockquote></p><p> The current shortage centers around less-advanced chips used in making integrated circuits (ICs) and microcontrollers and comes as foundries such as Taiwan Semiconductor Manufacturing Co Ltd(2330.TW)shift their focus on making higher-margin, cutting-edge chips used in smart phones and laptops.</p><p><blockquote>目前的短缺主要集中在用于制造集成电路(IC)和微控制器的不太先进的芯片上,而台积电股份有限公司(2330.TW)等代工厂将重点转向制造用于制造利润更高的尖端芯片。智能手机和笔记本电脑。</blockquote></p><p> That, in turn, has helped GlobalFoundries, which is the world's third-largest foundry by revenue, to stay competitive in that segment of the market.</p><p><blockquote>这反过来又帮助全球收入第三大代工厂GlobalFoundries在该细分市场保持竞争力。</blockquote></p><p> The company forecast fourth-quarter revenue of between $1.8 billion and $1.83 billion, the low end of which was in line analyts' estimates, according to Refinitiv data.</p><p><blockquote>根据Refinitiv的数据,该公司预计第四季度营收在18亿美元至18.3亿美元之间,其低端符合line analyts的预期。</blockquote></p><p> GlobalFoundries posted revenue of $1.7 billion and a profit of 7 cents per share for the third quarter ended Sept. 30, both of which beat Wall Street's estimates.</p><p><blockquote>格芯公布截至9月30日的第三季度营收为17亿美元,每股利润为7美分,均超出华尔街预期。</blockquote></p><p> Chief Executive Officer Tom Caulfield said higher wafer output primarily drove revenue growth.</p><p><blockquote>首席执行官Tom Caulfield表示,更高的晶圆产量主要推动了收入增长。</blockquote></p><p> Still, the company's gross margins remained markedly low at about 18% in the latest quarter, compared with foundry rivals TSMC and Intel, whose gross margins came in well above 50%.</p><p><blockquote>尽管如此,该公司最近一个季度的毛利率仍明显较低,约为18%,而代工竞争对手台积电和英特尔的毛利率远高于50%。</blockquote></p><p> Shares of the company rose 1.27% in extended trading. They have risen nearly 50% since going public, valuing the company at more than $37 billion.</p><p><blockquote>该公司股价在盘后交易中上涨1.27%。自上市以来,它们已上涨近50%,公司估值超过370亿美元。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源:<a href=\"https://www.reuters.com/technology/globalfoundries-posts-56-rise-quarterly-sales-booming-chip-demand-2021-11-30/\">Reuters</a></p>\n<p>为提升您的阅读体验,我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GFS":"GLOBALFOUNDRIES Inc."},"source_url":"https://www.reuters.com/technology/globalfoundries-posts-56-rise-quarterly-sales-booming-chip-demand-2021-11-30/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1122277459","content_text":"GlobalFoundries(GFS.O)forecast upbeat current-quarter sales on Tuesday, in its first earnings update after going public in October, banking on a spike in chip demand as companies scramble to secure supplies amid a global semiconductor crunch.\nThe Malta, New York-based company makes silicon wafers for chip designers such as Advanced Micro Devices, Broadcom Inc and Qualcomm Inc, which do not have their own fabrication plants, called fabs.\nAlthough the pandemic has fueled demand for laptops, mobile phones and cars, it has also exacerbated a worldwide shortage of semiconductor chips, forcing automakers and electronic firms to curtail production and delay rollouts of new products.\nThe current shortage centers around less-advanced chips used in making integrated circuits (ICs) and microcontrollers and comes as foundries such as Taiwan Semiconductor Manufacturing Co Ltd(2330.TW)shift their focus on making higher-margin, cutting-edge chips used in smart phones and laptops.\nThat, in turn, has helped GlobalFoundries, which is the world's third-largest foundry by revenue, to stay competitive in that segment of the market.\nThe company forecast fourth-quarter revenue of between $1.8 billion and $1.83 billion, the low end of which was in line analyts' estimates, according to Refinitiv data.\nGlobalFoundries posted revenue of $1.7 billion and a profit of 7 cents per share for the third quarter ended Sept. 30, both of which beat Wall Street's estimates.\nChief Executive Officer Tom Caulfield said higher wafer output primarily drove revenue growth.\nStill, the company's gross margins remained markedly low at about 18% in the latest quarter, compared with foundry rivals TSMC and Intel, whose gross margins came in well above 50%.\nShares of the company rose 1.27% in extended trading. They have risen nearly 50% since going public, valuing the company at more than $37 billion.","news_type":1,"symbols_score_info":{"GFS":0.9}},"isVote":1,"tweetType":1,"viewCount":2115,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"lives":[]}